Trisenox, an injectable form of ARSENIC
November 2000
The FDA just approved Trisenox, an injectable form of ARSENIC.
Trisenox (arsenic trioxide) is for second-line therapy of acute promyelocytic leukemia. It's very effective...up to 70% remission in patients who don't do well on standard chemotherapy.
Trisenox has an interesting origin. Scientists discovered arsenic was a common ingredient in some traditional Chinese remedies for leukemia.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote